Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
about
Testing of candidate single nucleotide variants associated with paclitaxel neuropathy in the trial NCCTG N08C1 (Alliance)Neuropathic cancer pain: What we are dealing with? How to manage it?Chemotherapy-induced peripheral neurotoxicity: a critical analysisSequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathyComparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled studyPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience.Therapeutic strategies for cancer treatment related peripheral neuropathies.Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer.Paclitaxel induces acute pain via directly activating toll like receptor 4Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.Urinary N telopeptide levels in predicting the anti-nociceptive responses of zoledronic acid and paclitaxel in a rat model of bone metastases.The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment ScaleClinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).Neurotoxic 1-deoxysphingolipids and paclitaxel-induced peripheral neuropathyChemotherapy-induced peripheral neuropathy: Current status and progress.National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons.Docetaxel-associated myalgia-arthralgia syndrome in patients with breast cancer.Leg pain and gynecologic malignancy.Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.Taxane-induced arthralgia and myalgia: A literature review.Anti-nociceptive roles of the glia-specific metabolic inhibitor fluorocitrate in paclitaxel-evoked neuropathic pain.A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.Potentiation of Paclitaxel-Induced Pain Syndrome in Mice by Angiotensin I Converting Enzyme Inhibition and Involvement of Kinins.Chemotherapy-induced peripheral neuropathy: A current review.Pain in chemotherapy-induced peripheral neurotoxicity.Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.Efficacy and safety of duloxetine in Chinese breast cancer patients with paclitaxel-induced peripheral neuropathy.The Content Validity of a Chemotherapy-Induced Peripheral Neuropathy Patient-Reported Outcome Measure.Lack of paclitaxel effects on intracranial self-stimulation in male and female rats: comparison to mechanical sensitivity.Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.Chemotherapy-related neuropathic symptom management: a randomized trial of an automated symptom-monitoring system paired with nurse practitioner follow-up.Pain in Platin-Induced Neuropathies: A Systematic Review and Meta-Analysis.Structural improvement of new thiazolidinones compounds with antinociceptive activity in experimental chemotherapy-induced painful neuropathy.Risk of docetaxel-induced peripheral neuropathy among 1,725 Danish patients with early stage breast cancer.The anticonvulsant enaminone E139 attenuates paclitaxel-induced neuropathic pain in rodents.In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.
P2860
Q24289538-24E96B08-CBCF-44CA-B33E-08ABC6DC1F8EQ26998945-403D36DE-EA8E-46EC-AC53-CDF25E6C07B5Q27010318-E4EB4681-DAED-450B-87A1-4EED09513957Q30399701-2D944460-C746-4B9B-B0DA-A13BAFC0E8D2Q33650951-068159E3-AA72-4261-AFA2-99C3D92621B6Q33711444-76485B34-920A-48E1-BA4A-99F1D4DD3525Q33717608-6C01E01C-78E5-463F-B3E7-03AEF43C647EQ33744706-E6826B62-8136-477C-8EA8-F87AF575D17EQ33984071-618EB026-4B2D-471B-92F9-18D74D436E33Q34433406-22B63C3A-26F3-4B8C-A281-6DBA17276E65Q35002187-B04DCC9A-D31F-4331-8D66-6A98DE207D06Q35187300-C5C2511D-0154-4688-AA6B-3410CF0482A0Q35248222-1A7DD23D-0C7C-4D26-A773-B3A13CAFE75BQ35919801-7FC8B209-7B19-47F7-B9DA-733BD50ACD70Q36106866-9C7C8186-6147-418D-BBE3-61A017CBF035Q36117942-61C823F7-1581-4C12-A3EE-E6A8774783CEQ36162504-A4FB385F-86D8-4534-9D20-D523011B9596Q36171312-DF831467-155B-4472-9646-DB8025E3728DQ36421901-08D73A8B-999F-49D7-B3A8-4B910EB91C0DQ37364316-87ED51D2-DD83-413A-9B3C-6D0ECA5F6208Q37610473-19424F73-71F3-445D-9308-189D0F7CF35AQ38046830-D983B796-E9DD-4141-A2A8-8EB81C5A0A58Q38224422-1249D173-4CEE-4D92-9E6E-708D0A9A9D73Q38711952-64CDDE91-824B-4EF5-A3AE-3EB4AAA85E22Q38750007-FDB69826-7596-4E68-B732-99CD1F1ED572Q38759777-E9C16727-F8D2-464F-8C43-1336A484FA6CQ39187514-C71F9476-2977-4BBB-B630-E55F0CDD7818Q39293928-C62069F9-088C-44FF-B630-6233B08B5132Q39363713-46F1F0A7-76E9-4ABF-828A-CE9B83E400CBQ40757672-527DCFBC-06E0-4EC5-9649-797BCA99B6DEQ47162434-350259DB-1A45-4EA1-ADD3-AD3DE915E948Q47293439-9DEA9AE5-1AF4-4960-BE58-5CC79350674CQ47549208-D6EBC1D3-89D3-41CE-9EB2-CAB6DC38CB8AQ47552411-284CB08E-31CD-4433-8BBA-D0962603EB29Q47569311-1FC2E266-803E-47A0-BC06-B87560A84901Q48192466-D4973516-8BCF-4968-8651-B5D3BC97E34EQ48323975-4A0A9211-BD52-47BD-BEB6-456943540726Q50560002-1C73C150-A08F-424E-98DA-C0ACD1449CFBQ54377281-E2FDFC54-CDEE-4FBA-BCBB-432FE8FFED86Q55241487-13B17F10-768C-4DF8-8B7D-93F5980EAA01
P2860
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Further data supporting that p ...... r Treatment Group trial N08C1.
@ast
Further data supporting that p ...... r Treatment Group trial N08C1.
@en
Further data supporting that p ...... r Treatment Group trial N08C1.
@nl
type
label
Further data supporting that p ...... r Treatment Group trial N08C1.
@ast
Further data supporting that p ...... r Treatment Group trial N08C1.
@en
Further data supporting that p ...... r Treatment Group trial N08C1.
@nl
prefLabel
Further data supporting that p ...... r Treatment Group trial N08C1.
@ast
Further data supporting that p ...... r Treatment Group trial N08C1.
@en
Further data supporting that p ...... r Treatment Group trial N08C1.
@nl
P2093
P2860
P356
P1433
P1476
Further data supporting that p ...... r Treatment Group trial N08C1.
@en
P2093
Anthony J Jaslowski
Arif Kamal
Brandi N Reeves
Charles L Loprinzi
Daniel H Lachance
Gamini S Soori
Jeff A Sloan
Joseph Kelaghan
Kelli N Burger
Nguyet A Le-Lindqwister
P2860
P304
P356
10.1002/CNCR.27489
P407
P577
2012-03-13T00:00:00Z